Allianz Asset Management’s Westamerica Bancorp WABC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$265K Hold
5,080
﹤0.01% 1917
2025
Q4
$243K Hold
5,080
﹤0.01% 1917
2025
Q3
$254K Sell
5,080
-1,500
-23% -$74.3K ﹤0.01% 1934
2025
Q2
$319K Sell
6,580
-15,900
-71% -$762K ﹤0.01% 1900
2025
Q1
$1.14M Buy
22,480
+5,600
+33% +$285K ﹤0.01% 1650
2024
Q4
$886K Sell
16,880
-21,593
-56% -$1.16M ﹤0.01% 1675
2024
Q3
$1.9M Sell
38,473
-26,539
-41% -$1.35M ﹤0.01% 1428
2024
Q2
$3.16M Sell
65,012
-7,200
-10% -$344K ﹤0.01% 1145
2024
Q1
$3.53M Buy
72,212
+36,266
+101% +$1.76M 0.01% 983
2023
Q4
$2.03M Hold
35,946
﹤0.01% 1316
2023
Q3
$1.55M Sell
35,946
-7,710
-18% -$345K ﹤0.01% 1550
2023
Q2
$1.67M Buy
43,656
+32,700
+298% +$1.31M ﹤0.01% 1362
2023
Q1
$485K Sell
10,956
-7,899
-42% -$425K ﹤0.01% 1906
2022
Q4
$1.11M Buy
+18,855
New +$1.11M ﹤0.01% 1483

Other funds holding WABC

Allianz Asset Management's WABC Position: Q1 2026 in Review

Allianz Asset Management held its Westamerica Bancorp (WABC) position steady in Q1 2026 at 5,080 shares worth $265K. The position accounts for ﹤0.01% of the portfolio, ranked #1917.

Allianz Asset Management first reported a position in WABC in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.53M in Q1 2024. 204 funds tracked by Wall St. Rank hold WABC as of Q1 2026.

  • Allianz Asset Management held 5,080 shares of Westamerica Bancorp worth $265K as of Q1 2026.
  • Allianz Asset Management left its Westamerica Bancorp share count unchanged in Q1 2026.
  • Westamerica Bancorp made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1917 holding.
  • Allianz Asset Management first reported a position in Westamerica Bancorp in Q4 2022 and has held it in 14 quarters since.
  • Allianz Asset Management's Westamerica Bancorp position peaked at $3.53M in Q1 2024.
  • 204 funds tracked by Wall St. Rank held Westamerica Bancorp as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.